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D-dimerAbstract Introduction: Pleural effusion is a common clinical presentation in several diseases. Var-
ious parameters from pleural ﬂuid have been studied to identify the cause of effusion. D-dimer is a
degradation product of cross-linked ﬁbrin and alkaline phosphatase (ALP) is one of the biochem-
ical markers found in pleural effusion. ALP is a plasma membrane derived enzyme of uncertain
physiologic function that hydrolyzes synthetic phosphate esters at pH 9. It is present in the serum
in several forms, i.e., ALP-1 alpha 2, ALP-2 beta 1 and ALP-3 beta 2.
Aim: The present study was carried out to evaluate the value of alkaline phosphatase and D-
dimer concentration in the pleural effusions and serum as a diagnostic tool.
Methods: This study was carried out on one hundred patients with pleural effusions of different
aetiologies. 75 patients had exudative pleural effusions (35 patients had tuberculous effusion, 20
patients had malignant effusion, 10 had parapneumonic effusion, 5 had empyema and 5 patients
had systemic lupus erythematosis) and 25 patients had transudative effusions (20 patients had hepa-
tic and 5 patients had cardiac effusions). Serum and pleural effusion D-dimer (measured by
ELISA), ALP, LDH and protein levels were measured.
Results: There was a highly signiﬁcant difference in the pleural ﬂuid D-dimer and ALP levels
between exudative and transudative effusions (P< 0.001). Also, there was a highly signiﬁcant dif-
ference in both the pleural ﬂuid D-dimer and ALP levels between tuberculous and non tuberculous
pleural effusions (P< 0.001). There were no signiﬁcant differences in the pleural levels of either the
D-dimer or the ALP between malignant and non malignant pleural effusions (P> 0.05). Lastly
there was no signiﬁcant difference (P> 0.05) in the serum levels of either the ALP or the D-dimer
between different types of effusions.
Conclusion: Measurement of pleural ﬂuid D-dimer and ALP levels aids in the differentiation
between exudative and transudative pleural effusions. Also, both pleural ﬂuid D Dimer and ALP
are signiﬁcantly higher in tuberculous pleural effusions.
ª 2014 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. Open access under CC BY-NC-ND license.le: +20
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Figure 1 Distribution of exudative and transudative pleural
effusions in the study.
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A correct diagnosis of the underlying disease is essential for
rationale management of pleural effusion. Transudative pleu-
ral effusion is caused by a limited number of diseases, whereas
the exudative effusion requires more extensive diagnostic
investigations. Therefore, the ﬁrst step is to classify them as
transudate or exudate effusion, even if this differentiation does
not contribute to the etiological diagnosis. Diagnosing the
etiology of pleural effusion clinically with certainty is a chal-
lenging task for physicians. Various pleural ﬂuid parameters
have been used to identify the cause. Light et al. [1] have
classiﬁed pleural effusions into transudate and exudate using
pleural ﬂuid protein and LDH concentrations.
Coagulation system plays an important role in pleural dis-
eases. Understanding the pathophysiological mechanisms of
the coagulation and pleural disorders may open possibilities
for novel diagnostic and therapeutic approaches. Several
studies have reported that exudative pleural effusion is associ-
ated with enhanced local ﬁbrinolytic activity. Thus, D-dimer
level; a marker of solid phase ﬁbrin dissolution; was found
to be high in patients with exudative pleural effusion [2,3].
Tuberculosis (TB) remains a public health problem world-
wide. According to the latest 2012 global tuberculosis report,
in 2011; there were 8.7 million new cases of TB and 1.4 million
people died from TB, including almost 1 million deaths among
HIV-negative individuals and 430,000 among people who were
HIV-positive [2]. Tuberculous pleural effusion (TPE) occurs in
up to 30% of patients with TB and constitutes the major
portion of the extrapulmonary TB morbidity [3]. To establish
or exclude TPE diagnosis is of great importance when dealing
with patients with pleural effusion [4,5].
Methods
This study included 100 patients with pleural effusion admitted
to the Chest department; Menouﬁa University Hospital. All
patients were subjected to the following after taking an
informed consent: detailed history taking, general and local
chest examination, plain chest X-ray postero–anterior and
lateral views and chest CT (Computed Tomography) when
needed, routine laboratory investigations, electrocardiography
(ECG) and echocardiography, tuberculin skin test, sputum
examination for AFB (acid fast bacilli) by ZN (Ziehl Nielsen)
staining when needed, serum protein and LDH (lactate dehy-
drogenase), pleural ﬂuid protein and LDH, pleural ﬂuid gram
stain and bacterial culture, pleural ﬂuid ZN staining for AFB,
assessment of pleural ﬂuid ADA (adenosine deaminase) level,
cytological examination of the pleural ﬂuid, blind pleural
biopsy by Abram’s needle and/or thoracoscopy when needed
to reach the diagnosis. Lastly assessment of the levels of D
dimer and ALP in both serum and pleural ﬂuid was done for
all patients.
Results
Fig. 1 shows that hundred pleural effusion patients were stud-
ied; 75% were exudative effusions (35% tuberculous, 20%
malignant, 10% parapneumonic, 5% empyema and 5% colla-
gen) and 25% were transudative effusions (20% hepatic and
5% cardiac).Table 1 shows that, there were highly signiﬁcant differences
between exudative and transudative effusions according to the
pleural levels of ALP and D-dimer (p< 0.001), but there were
no signiﬁcant differences according to the serum levels of ALP
and D-dimer (p> 0.05).
Table 2 shows that, there were highly signiﬁcant differences
between tuberculous and non tuberculous effusions according
to the pleural levels of ALP and D Dimer (p< 0.001), but
there were no signiﬁcant differences regarding the serum levels
of ALP and D Dimer (p> 0.05).
Table 3 shows that, there were no signiﬁcant differences
according to the serum and pleural levels of ALP and D-dimer
(p> 0.05).
Discussion
Our results revealed a highly signiﬁcant difference between
exudative and transudative pleural effusions regarding both
pleural ﬂuid ALP and D-dimer levels [(100.47 ± 43.17 in
exudates versus 54.4 ± 10.8 in transudates for pleural ALP
and 0.72 ± 0.2 in exudates versus 0.12 ± 0.02 in transudates
for pleural D Dimer (<0.001 for both)] (Table 1).
Our results coincided with those found by Mushtaq A.
Lone et al. [6] in 2002 in their Indian study, they reported that
ALP levels were greater than 75 mg/dl in 72 out of 84 exudates
but none in 17 transudates. They estimated a sensitivity of
ALP estimation for the diagnosis of exudates of 100% and a
speciﬁcity of 85.71%. The positive predictive value was
58.62%, while the negative predictive value was 100%. Isabel
Gazquez et al. [7] reported that the sensitivity and speciﬁcity
of pleural ALP for an exudate were calculated at 97% and
75% respectively. The mean ± SD pleural ALP concentration
was 55.7 ± 39.06 U/L in the transudates while it was
121.35 ± 136 U/L for exudates. Also, Tahaoglu et al. [8] and
Syabbalo [9] found that the differences between the pleural
ALP mean values of the transudate group and the exudate
group were statistically signiﬁcant (p< 0.001).
Regarding the D Dimer, Astedt et al. [10] found increased
levels of ﬁbrin degradation products including D Dimer in exu-
dative malignant and infectious effusions when compared to
transudates while Costa Vaz et al. [11] found no signiﬁcant
Table 1 Comparison between exudative and transudative effusion levels of ALP and D-dimer in serum and effusion.
Exudate Mean ± SD Transudate Mean ± SD t test p Value
Serum ALP 248.93 ± 101.96 240.07 ± 76.24 0.4 >0.05
Pleural ALP 100.47 ± 43.17 54.4 ± 10.8 5.3 <0.001**
Serum D Dimer 0.69 ± 0.29 0.58 ± 0.19 1.6 >0.05
Pleural D Dimer 0.72 ± 0.2 0.12 ± 0.02 17.3 <0.001**
p> 0.05 non signiﬁcant & p< 0.05 signiﬁcant & p< 0.001** highly signiﬁcant.
Table 2 Comparison between tuberculous and non tuberculous effusion levels of ALP and D-dimer in serum and effusion.
Non TB Mean ± SD TB Mean ± SD t test p Value
Serum.ALP 212.62 ± 92.22 258.86 ± 95.44 2.363 >0.05
Pleural.ALP 66.77 ± 22.24 130.14 ± 41.12 10.022 <0.001**
Serum D Dimer 0.51 ± 0.54 0.64 ± 0.14 1.469 >0.05
Pleural D Dimer 0.42 ± 0.29 0.99 ± 0.08 8.613 <0.001**
p> 0.05 non signiﬁcant & p< 0.05 signiﬁcant & p< 0.001** highly signiﬁcant.
Table 3 Comparison between malignant and non malignant effusion levels of ALP and D-dimer in serum and effusion.
Malignant Mean ± SD Non malignant Mean ± SD t test p Value
Serum ALP 278.55 ± 74.68 238.74 ± 99.3 1.7 >0.05
Pleural ALP 92.38 ± 45.52 75.25 ± 25.29 1.617 >0.05
Serum D Dimer 0.83 ± 0.68 0.65 ± 0.23 2.01 >0.05
Pleural D Dimer 0.61 ± 0.09 0.49 ± 0.42 1.583 >0.05
Value of D-dimer and alkaline phosphatase in the diagnosis of pleural effusion 871differences regarding pleural D Dimer levels between transu-
dates and exudates (p= 0.277).
Also, Table 2 reveals a highly signiﬁcant difference between
tuberculous and non tuberculous pleural effusions according
to the pleural levels of ALP and D Dimer (p< 0.001),
both were signiﬁcantly higher in tuberculous than non
tuberculous effusions [130.14 ± 41.12 in TB effusions versus
66.77 ± 22.24 in non TB effusions for pleural ALP and
0.99 ± 0.08 in TB effusions versus 0.42 ± 0.29 in non TB
effusions for pleural D Dimer (P< 0.001 for both)]. Table 3
shows no signiﬁcant differences between malignant and non
malignant pleural effusions regarding pleural or serum ALP
or D Dimer (P> 0.05).
Jadhav et al. [12] reported that the values of pleural ALP
and pleural to serum ALP ratio were signiﬁcantly higher in
TPE than other causes of pleural effusion. Also they found
that the sensitivity and speciﬁcity of the pleural ALP for the
diagnosis of TPE were 90% and 80%, respectively, for a cut
off level of 71 IU/L (p< 0.0001) and those of the pleural to
serum ALP ratio were 90% and 86.66%, respectively, for a
cut off value of 51.1 (p< 0.0001). Metintas et al. [13] found
that pleural ALP and pleural to serum ALP ratio were
signiﬁcantly raised in TPE compared to non TPE. On the other
hand, Carrion F and Perpina [14] found that pleural ALP was
signiﬁcantly elevated in malignant pleural effusion compared
to TPE and other causes of pleural effusion.
Regarding the pleural ﬂuid D dimer, the study done by
Shen et al. [15] in 2013 investigated the pleural levels of
D-dimer and their diagnostic roles for TPE. They found
that the concentrations of pleural D-dimer in TPE
(1082.66 ± 453.83 mg/l FEU) were signiﬁcantly higher than
those in non-TPE (319.98 ± 266.78 mg/l FEU) (p< 0.05).They also found that the plasma D dimer levels were also
signiﬁcantly different between samples from TPE compared
to other etiologies (p< 0.05). They concluded that D-dimer
may be a possible marker for TPE with a sensitivity of
84.38% and speciﬁcity of 85.45% with a cut-off value of
622.5 mg/L FEU.
Lu et al. [16] reported that D-dimer levels were signiﬁcantly
higher in pleural ﬂuid from patients with tuberculous pleuritis
and empyema than those in pleural ﬂuid from patients with
malignant pleural effusions. Philip-Joe¨t et al. [17] also noticed
that D-dimer levels in patients with tuberculosis tend to be
higher than in patients with heart failure, empyema, and/or
malignant pleural effusion, although there was no signiﬁcance.
On the other hand, Matveychuk et al. [18] found high D
dimer levels among malignant pleural effusions, and concluded
that D-dimer might be useful as a simple, noninvasive,
surrogate marker for malignant pleural effusion. Also, Costa
Vaz et al. [11] found no signiﬁcant differences between
parapneumonic, tuberculous and malignant pleural effusions
regarding the pleural levels of D Dimer.
Conclusion
Measurement of pleural ﬂuid D-dimer and ALP levels aids in
the differentiation between exudative and transudative pleural
effusions. Also, both pleural ﬂuid D Dimer and ALP are
signiﬁcantly higher in tuberculous pleural effusions.
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